Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial

Completed

Conditions studied: Hepatitis C

In brief

The primary purpose of this study is to determine whether the hepatitis C virus continues to remain unable to be detected in subjects who were previously treated with BMS-914143 and achieved sustained virologic response

Key facts

Study ID

NCT01525810

Run by

Bristol-Myers Squibb

People needed

218

Starts

2012-03-01

Expected to finish

2014-11-01

Last updated by the study team

2015-03-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects must have received Lambda in a previous trial and have Hepatitis C virus (HCV) Ribonucleic acid (RNA) < LOQ at the completion of the required post-treatment follow-up (must enter this study within 6 months of completion of the required post-treatment follow-up in the previous trial) NOTE: For blinded parent trials, subjects who have HCV RNA <LOQ at the completion of the required post-treatment follow-up may enter this study without knowledge of their treatment assignment in the parent study. Subjects who received control agents (eg, pegylated-interferon alfa) in the previous protocol will be allowed to participate until unblinded treatment information is released; at that time subjects will have the option to continue in the study

You may not qualify if…

• Subjects must not have been treated with any antiviral or immunomodulatory drug for chronic hepatitis C after completion of the previous study of Lambda

Where it is running

• Yale University School Of Medicine — New Haven, Connecticut, United States
• Orlando Immunology Center — Orlando, Florida, United States
• Gastrointestinal Specialists Of Georgia — Marietta, Georgia, United States
• The Queen'S Medical Center — Honolulu, Hawaii, United States
• Henry Ford Health System — Detroit, Michigan, United States
• Mayo Clinic — Rochester, Minnesota, United States
• Duke University Medical Center — Durham, North Carolina, United States
• Consultants For Clinical Research — Cincinnati, Ohio, United States
• Texas Clinical Research Institute — Arlington, Texas, United States
• St. Luke'S Episcopal Hospital - Baylor College Of Medicine — Houston, Texas, United States
• University Of Texas Health Science Center At Houston — Houston, Texas, United States
• Va Medical Center (151) — Houston, Texas, United States
• Texas Liver Institute — San Antonio, Texas, United States
• Clinical Research Centers Of America — Murray, Utah, United States
• Metropolitan Research — Annandale, Virginia, United States
• Virginia Mason Medical Center — Seattle, Washington, United States
• Local Institution — Buenos Aires, Buenos Aires, Argentina
• Local Institution — Buenos Aires, Buenos Aires, Argentina
• Local Institution — Buenos Aires, Buenos Aires, Argentina
• Local Institution — Mar del Plata, Buenos Aires, Argentina
• Local Institution — Rosario, Santa Fe Province, Argentina
• Local Institution — Buenos Aires, Argentina
• Local Institution — Camperdown, New South Wales, Australia
• Local Institution — Darlinghurst, New South Wales, Australia
• Scripps Clinic — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.